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Glutamine, which is expected to be produced by C6 glioma cells, is not detected in both amino-acid analyses and “C-NMR spectra of perchloric 
acid extracts of cells incubated for 4 h with [I-“C]glucose in the absence of extracellular glutamine. However, the resonances of a glutamate-linked 
product are observed in these spectra. The analysis of the pH dependence of chemical shifts from various glutamate-derived compounds shows 
that the observed resonances came from glutathione. Glutamine and glutathione signals are in close proximity on the frequency scale, leading to 
possible misinterpretation of the spectra. 
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1. INTRODUCTION 
Since the work of Martinez-Hemandez et al. [ 1] who 
demonstrated the glial localization of glutamine synthe- 
tase, glial cells and particularly astrocytes are assumed 
to produce glutamine in brain. It is generally acknowl- 
edged that this amino acid is released from astrocytes 
and taken up by neurons wherein it is converted into 
glutamate or y-aminobutyric acid (GABA), two major 
neurotransmitter amino acids [2]. After neurotransmis- 
sion, the amino acid is inactivated partly by recapture 
by astrocytes where it is recycled into glutamine or oxi- 
dized in the Krebs cycle [2]. Some recent papers [3-61 
have reported the use of cultured cells in conjunction 
with 13C- or ‘H-NMR techniques to study the respective 
role of glial cells and neurons in the compartmentation 
of brain glutamate metabolism. In these studies, pri- 
mary cultures of astrocytes and neurons have been incu- 
bated with 13C-enriched glucose [3,6], pyruvate [5] or 
acetate [6], resulting in the isotopic enrichment of inter- 
mediary metabolites, particularly glutamate and glu- 
tamine. 
normal and tumor cells. Since it is known that tumor 
cells require glutamine in the medium to grow [7], we 
have investigated the ability of C6 cells incubated in a 
glutamine-free medium to synthesize glutamine from 
glucose. Here, we report that glutamine is not detected 
in C6 cells, either by amino acid analysis or by 13C- 
NMR of extracts of cells incubated with [l-13C]glucose. 
2. EXPERIMENTAL 
2.1. Materials 
Dulbecco’s modified Eagle’s media (DMEM) with or without glu- 
cose, glutamine and pyruvate were supplied by Gibco (USA). 
[I-“C]Glucose was purchased from the CEA (France). Glutamate, 
glutamine, glutathione and pyroglutamate were from Sigma (France). 
2.2. Cell culture and incubation with [I-“C]glucose 
The metabolism of brain tumor cell lines, such as the 
C6 glioma or the NIE-I 15 neuroblastoma line, has also 
been investigated with the same approach [3,5]. These 
studies showed some metabolic differences between 
C6 cell culture and incubation with [I-“Clglucose were performed 
as previously described [3]. Cells used in this study were taken between 
the 15th and 30th passage. Approximately 3. 10’ cells were washed 
twice with phosphate-buffered saline (PBS) and incubated at 37‘C in 
DMEM deprived of glutamine and pyruvate, but containing 5.5 mM 
99% enriched [I-“C]glucose. After a 4-h (or 48-h as indicated in the 
text) incubation period, the medium was removed and the cells were 
washed twice with PBS. Cell perchloric acid extracts were prepared as 
described in Portais et al. [3]. The neutralized extracts were passed 
through a Chelex-100 column (H+ form) and freeze-dried. The result- 
ing lyophilized powders were dissolved in D,O containing 0.1 M phos- 
phate buffer (pH 7.4) before NMR analyses. The amino acid content 
of the extracts were determined with an Applied Biosystem amino acid 
analyzer. 
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2.3. NMR spectroscopy 
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; GSH, 
glutathione; PBS, phosphate-buffered saline; GFAP, glial fibrillary 
acidic protein. 
NMR measurements were carried out on a Bruker AM 400 spec- 
trometer with a 5 mm broad-band probe-head. 13C-NMR spectra were 
acquired at 100.6 MHz, using a 63.5” flip angle, 0.5 s interpulse delay 
and 16K memory size. A proton decoupling (WALTZ-16, 1W) was 
applied during both the acquisition and the relaxation delay. Chemical 
shifts were expressed as ppm relative to the resonance at 63.3 ppm at 
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pH 7.4 of ethylene glycol used as reference. The chemical shafts of 
pyroglutamate were determined by analyzing a solution containing 50 
mM ethylene glycol and 50 mM pyroglutamate. in D,O buffered at 
pH 7.4 with 100 mM phosphate. To determine the pH dependences 
of glutamate, glutamine and glutathione resonances, two standard 
solutions were prepared in D,O; they contained either 50 mM gluta- 
mate and 100 mM glutathione or 50 mM glutamate and 100 mM 
glutamine, respectively. Both solutions contained 50 mM ethylene 
glycol as a reference. Prior to the “C-NMR analyses, aliquots of these 
solutions were adjusted to pH 3, 5, 7.4,9 and 11 (without correctton 
for isotopic effect), by adding NaOH or HCl. 
3. RESULTS 
Fig. 1 (spectrum A) shows the 15-65 ppm region of 
a perchloric acid extract from C6 glioma cells incubated 
for 4 h in a medium containing 5.5 mM [ 1-13C]glucose 
and deprived of glutamine and pyruvate. The peaks on 
this spectrum correspond to resonances of enriched car- 
bons as the control spectrum, obtained under the same 
conditions from an extract of cells incubated with natu- 
ral abundant glucose, which displays only very low sig- 
nals apart from those of inositol carbons (spectrum not 
shown). As previously reported [3], the metabolism of 
[ 1 -‘3C]glucose leads to the enrichment of various metab- 
olite carbons, particularly glutamate C2 (55.4 ppm), C3 
(27.7 ppm) and C4 (34.2 ppm) which give the most 
prominent peaks in spectrum A. The ratios between the 
intensities of the three resonances at 54.9,27.0 and 32.1 
ppm (noted X, Y and Z in spectrum A) to that of 
glutamate C2, C3 and C4, respectively, are very similar, 
suggesting they corresponded to a metabolite closely 
related to glutamate metabolism. In previous studies, 
these resonances have been assigned to glutamine [3,5]. 
However, the amino acid analysis of the cell extracts 
demonstrated that they did not contain glutamine. Con- 
trol experiments were carried out where a standard of 
glutamine was added to the cells after the incubation 
period but prior to the extraction. In that case, gluta- 
mine in the extract was correctly determined by amino 
acid analysis. Glutamine was also detected in extracts 
from C6 cells incubated in the routine DMEM, that 
contains 5.5 mM glucose and 4 mM glutamine. In this 
case, the intracellular glutamine content at steady-state 
was about 110 nmol/mg of protein. These results indi- 
cated that glutamine could not be lost during the extrac- 
tion procedure and therefore, that the extracts from 
cells incubated with glucose in the absence of glutamine 
did not contain a detectable amount of glutamine. 
Glutamine was added to a C6 cell extract obtained 
after cell incubation with [l-13C]glucose prior to NMR 
analysis (Fig. 1, spectrum B). Although the resonances 
Table 1 
Chemical shifts of carbons 2, 3 and 4 of glutamate, glutamine and 
y-glutamyl moiety of glutathione at pH 7.4 
Chemical shift (ppm) 
c2 c3 c4 
Glutamate 55.4 27.7 34.2 
Glutamine 54.9 27.1 31.7 
Glutathione (y-glutamyl) 54.9 27.0 32.1 
Pyroglutamate 59.1 26.1 30.5 
The chemical shifts were determined from spectra of perchloric acid 
extract of C6 glioma cells, after addition of glutamine and glutathione. 
Pyroglutamate chemical shifts were determined by analyzing a stand- 
ard solution prepared in the same way as a perchloric acid extract. 
Chemical shifts are expressed relative to the resonance of ethylene 
glycol at 63.3 ppm (absolute reference: trimethylsilane). 
of glutamine C2 and C3 overlapped peaks X and Z, 
respectively, the resonance of glutamine C4 is located 
upfield from peak Y, demonstrating that the resonances 
X, Y and Z cannot be assigned to glutamine. We exam- 
ined the possibility of the presence of pyroglutamate, a
compound which can be easily synthesized from gluta- 
mate, but the chemical shifts of the pyroglutamate car- 
bons (C2: 59.1 ppm, C3: 26.1 ppm and C4: 30.5 ppm at 
pH 7.4) were very different from the three unassigned 
resonances. The involvement of another compound, 
glutathione (GSH), which is also produced from gluta- 
mate, was then examined. Fig. 1C shows the spectrum 
obtained after addition of GSH to the C6 cell extract to 
which glutamine has been previously added. The three 
resonances arising from the y-glutamyl moiety of GSH 
overlapped the peaks X, Y and Z, suggesting that GSH 
was a good candidate for the assignment of these peaks. 
Other resonances from GSH, corresponding to the 
glycyl- and cysteinyl-moieties, were also observed in 
spectrum C. These resonances were not present in spec- 
trum A, indicating that they corresponded to carbons 
remaining unenriched after cell incubation with 
[ 1- 13C]glucose. 
Table I reports the chemical shifts of carbons 2,3 and 
4 of glutamate, glutamine, GSH and pyroglutamate at 
pH 7.4. At this pH, glutamine and GSH C2 or C3 have 
very similar chemical shifts, precluding any distinction 
between these two compounds. In contrast, the chemi- 
cal shifts of C4 were slightly but sufficiently different to 
allow a distinction. 
We have assessed the pH dependences of glutamate, 
Fig. 1. Carbon-13 NMR spectra of C6 cell extract, before and after addition of glutamine and glutathione. This figure displays the 15-65 ppm 
region of spectra of: (A) extract from C6 cells incubated for 4 h in a medium containing [I-“C]glucose but no glutamine; (B) same extract after 
addition of glutamine; (C) same extract after addition ofglutathione. Each spectrum corresponds to an overnight data accumulation. The resonances 
of carbons 2 (C2), 3 (C3) and 4 (C4) of glutamate (GLU), glutamine (GLN) and y-glutamyl-glutathione (y-glu-GSH), as well as those of the 
cysteinyl-(cys-GSH) and glycyl-(gly-GSH) moieties of glutathione, are shown in spectra B and C, respectively correspond to the unassigned 
resonances in spectrum A. 
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Fig. 2. pH dependences of glutamate, glutamine and glutathione reso- 
nance chemical shifts. The chemical shifts of the resonances from 
carbons 2 (C2), 3 (C3) and 4 (C4) of glutamate (-a-), glutamine (-o-) 
and glutathione (--x--), were determined by 13C-NMR analyses of 
standard solutions at different pH, using ethylene glycol as internal 
reference. 
glutamine and y-glutamyl-GSH resonances, by analyz- 
ing standard solutions of these compounds adjusted to 
pH 3, 5, 7.4, 9 and 11. The plots of the chemical shifts 
versus pH values for the C2, C3 and C4 positions of 
glutamate, glutamine and y-glutamyl-GSH are given in 
Fig. 2. The results indicated that the chemical shift of 
each resonance was pH dependent. However, the chem- 
ical shifts for glutamine and y-glutamyl-GSH C2 or C3 
remained very similar, whereas the difference between 
the chemical shifts of C4 was nearly constant, whatever 
the pH value (on the pH range studied). The pH de- 
pendences of resonances X, Y and Z in spectra of C6 
cell extracts were identical to that of GSH C2, C4 and 
C3, indicating that they can be effectively assigned to 
GSH. 
Fig. 3 shows the spectrum of an extract prepared after 
a 48-h cell incubation with 5.5 mM [l-‘3C]glucose. As 
compared to spectrum A in Fig. 1, the resonances of the 
GSH carbons were more intense, and coupiing patterns 
linked to the presence of neighbou~ng ‘3C-enriched car- 
bons clearly detected. They were very similar to those 
of glutamate carbons (as shown in the expanded region 
of the spectrum containing the C4 resonances, Fig. 3), 
demonstrating the close relationship between the two 
compounds in terms of structure and metabolism. As- 
suming a metabolic steady-state, the higher intensity 
ratio between the resonances of GSH and glutamate in 
spectra from cells incubated for 48 h with [1-13C]glu- 
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Fig. 3. Carbon-13 NMR spectrum of a perchloric acid extract of C6 
cells incubated for 48 h in a mediumcontaining 5.5 mM [I-“Cjglucose. 
The spectrum, corresponding to an overnight accumulation (16K zero 
filling and 1 Hz line broadening). The homonuclear “C3-“C4 spin 
coupling (coupling constant I&) patterns of the resonances from the 
C4 of glutamate (GLU) and y-glutamyl-glutathione (y-glu-GSH) are 
shown in an expanded view of the spectrum. The percentages of 
[3,4-“C]glutamate and y-glutamyl-glutathione obtained from this 
spectrum are 21.2 and 20.5, respectively. I, glutamate C2 (55.4 ppm); 
2, y-glu-GSH C2 (54.9 ppm); 3, glutamate C4 (34.2 ppm); 4, y-giu- 
GSH C4 (32.1 ppm); 5, glutamate C3 (27.7 ppm); 6, y-glu-GSH C3 
(27.0 ppm). 
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case, as compared to 4 h incubations, suggested that the 
turnover of GSH was probably lower than that of gluta- 
mate. 
Under the assumption that the lack of glutamine in 
cells could be the consequence of a limiting amount of 
ammonia in the incubation medium, cell perchloric acid 
extracts were prepared after incubation of C6 cells in the 
[ 1 -13C]glucose containing medium supplemented with 3 
mM ammonium chloride. Additional experiments were 
performed with C6 cells cultured in the presence of 0.5 
mM dibutyryl-CAMP, a differentiation promoting 
agent, that was controlled to induce morphological dif- 
ferentiation and more intense GFAP-positive im- 
munoreactivity. In both cases, glutamine was never de- 
tected in the 13C-NMR spectra of the corresponding 
perchloric acid extracts, whereas GSH was (spectra not 
shown). 
4. DISCUSSION 
The present work reports that the resonances of glu- 
tathione but not those of glutamine were observed in 
13C-NMR spectra of perchloric acid extracts from C6 
glioma cells incubated with [ 1 -13C]glucose in the absence 
of extracellular glutamine. This conclusion was based 
on the fact that glutamine was not detected by amino 
acid analysis of the extracts, and on a close examination 
of the chemical shift of the C4 resonance of both com- 
pounds. Only the resonances of the y-glutamyl moiety 
of GSH were observed with relative enrichment and 
homonuclear spin coupling patterns for C2, C3 and C4 
similar to those of the homologous glutamate carbons, 
indicating that the observed glutathione was neosynthe- 
sized from enriched glutamate. 
Glutathione is known to be present in C6 cells at a 
rather high level (around 40 nmol/mg of protein) [8], 
and in primary cultured astrocytes [9]. Its production 
mainly depends on the extracellular content in cystine 
and glutamate, and is favoured when cysteine is high 
and glutamate low [8]. As the medium used in this study 
initially contained 0.2 mM cystine but no glutamate, it 
was therefore not surprising to detect glutathione in the 
13C-NMR spectra. However, in a previous report, we 
have assigned the corresponding resonances to gluta- 
mine [3]. The same misinterpretation has probably been 
done by others ([5] in Fig. 3b of their work, the reso- 
nance noted as Gln C4 is likely to be GSH C4). Such 
a confusion was the consequence of the similarity of 
glutamine and glutathione carbon chemical shifts, and 
of the fact that C6 glial cells were assumed to produce 
glutamine. However, it is noteworthy that the chemical 
shifts of C4 are sufficiently different to allow un- 
ambiguous assignment, whatever the pH of the extract 
(Table I, Fig. 2). The assignment can be erroneous when 
only one compound is detected and the pH not strictly 
controlled. 
Glutathione is known to play various roles in the 
synthesis and transport of proteins and DNA, enzyme 
activity, metabolism, and protection of cells [lo]. In 
general, glutathione is assumed to have antioxidant 
properties. It has recently been reported that a glutathi- 
one depletion is involved in the cytotoxic effect of gluta- 
mate in brain [l 13. It has also been shown that glutathi- 
one has specific binding sites in brain [12], and that it 
is released upon K’ depolarization [131, suggesting that 
it could act as a neuropeptide. Eventually, some authors 
have suggested that GSH could be an intermediary in 
the transfer of glutamate from astrocytes to neurons 
[ 141. Thus, there is an increasing need to further investi- 
gate the role of GSH in brain. The present work indi- 
cates that 13C-NMR studies of cultured cells offer an 
additional possibility in the field. Then it was interesting 
to question whether glutathione resonances were pres- 
ent in spectra obtained from primary cultured astro- 
cytes. Although they have not been assigned, it is likely 
that glutathione resonances, in addition to those of glu- 
tamine, are also present in 13C-NMR spectra of extracts 
from primary cultures of both cerebellar [3] and cortical 
[5,6] astrocytes and in spectra of extracts from neuron 
plus astrocyte co-cultures (resonance noted as unas- 
signed in Fig. 3 of [6]). Glutathione resonances also 
seem to be present in spectra from neuron and neuro- 
blastoma extracts [5]. 
An important result of the present study is the ab- 
sence of glutamine resonances in the 13C-NMR spectra 
of C6 cells. As it was verified that glutamine could not 
be degraded during the analytical procedure, this ab- 
sence appears to be linked either to the lack of gluta- 
mine formation from glucose or to a very low cellular 
content in glutamine. As it has been shown that gluta- 
mine synthetase is active in C6 cells [15], this result 
suggests that the activity of the enzyme is very low 
under our conditions of cell incubation with [l-‘3C]glu- 
case, i.e. in a medium deprived of glutamine. A simple 
explanation for this result could be that ammonium ions 
were limiting for the glutamine synthetase reaction. 
However, in experiments where C6 cells were incubated 
with [l-‘3C]glucose in the presence of 3 mM ammonium 
chloride, no more glutamine was produced. Another 
explanation could be that the cells were not sufficiently 
differentiated. In preliminary experiments where C6 
cells were cultured for 4 days in the presence of 0.5 mM 
dibutyryl-CAMP before incubation with [ 1 -13C]glucose, 
no glutamine was observed in the 13C-NMR spectra 
although two differentiation criteria (morphology and 
GFAP immunoreactivity) had evolved positively. Thus, 
although C6 cells have been used for years as a model 
of glial cells, they cannot be considered as astrocytes, 
that produce glutamine, but as immature glia that pos- 
sess astrocytic properties [15]. In this sense, they consti- 
tute a model for tumor cells. In our study, the weak 
glutamine production, if any, appears to be in accord- 
ance with the tumor nature of C6 cells, because it is 
known that tumor cells exhibit a requirement for glu- 
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tamine in the medium [7]. But, until now, the metabo- 
lism of glutamine in brain tumor cells has been poorly 
documented, in vitro as well as in vivo. If such a require- 
ment for glutamine occurs in the case of tumors growing 
in the brain (glioma being the major form of brain 
tumors), there would be a competition between eurons 
and tumor cells for the capture of the glutamine pro- 
duced by non-tumorous astrocytes. As a function of 
tumor growth, the part of glutamine available for neu- 
rons would decrease, leading to a considerable pertur- 
bation of the glutamate-glutamine cycle, and thus of 
brain function. Inoculation of C6 cells in the rat brain 
constitutes an interesting way to study both the metab- 
olism of tumor cells in situ and the impact of brain 
tumors on surrounding cells [ 161. Further characteriza- 
tion of the metabolism of these cells in vitro, and more 
particularly concerning the metabolism of glutamine, 
should also be helpful in interpreting in vivo data. 
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